✦ LIBER ✦

Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer

Book ID: 122091289
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 143 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)98858-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Whole-body 18F-fluorodeoxyglucose positr

✍ P. Lewis; P. Marsden; T. Gee; T. Nunan; M. Malsey; S. Griffin; J. Dussek 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 337 KB

Cancer screening with whole-body F-fluor

Cancer screening with whole-body F-fluorodeoxyglucose positron-emission tomography

✍ Seiei Yasuda; Akira Shohtsu 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 261 KB

Evaluation of fluorine-18-fluorodeoxyglu

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer

✍ Catherine A.B Saunders; Julian E Dussek; Michael J O’Doherty; Michael N Maisey 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Evaluation of fluorine-18-fluorodeoxyglu

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer

✍ Demura, Y; Ameshima, S; Ishizaki, T; Miyamori, I; Sasaki, M; Chiba, S; Ito, H; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Whole-body 18F-fluorodeoxyglucose positr

Whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer

✍ Yoshimasa Kitagawa; Sadahiko Nishizawa; Kazuo Sano; Norihiro Sadato; Yoshihiro M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Clinical value of whole-body positron em

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

✍ G. Beets; Professor F. Penninckx; C. Schiepers; L. Filez; L. Mortelmans; R. Kerr 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr